265) ated wounds were used as controls for the treatment groups (n = 4). |
266) Animals of the three treatment groups were given with different |
267) Animals were randomly divided into 4 treatment groups. |
268) ted polychromatic erythrocytes across the treatment groups. |
269) ters were appreciated between control and treatment groups. |
270) s significantly lower compared with other treatment groups. |
271) Treatment options are limited, with open s |
272) Treatment options differ depending on the |
273) Multiple treatment options exist and have variable |
274) plates are the most useful and effective treatment options for hypertrophic scars ( |
275) n and helping them to choose the adequate treatment options to control microbial inf |
276) t and critical attitudes to screening and treatment options. |
277) hypercoagulability did not resolve during treatment or for up to 1 month following a |
278) dosing, safety monitoring, and during of treatment or long-term outcomes for propra |
279) roup of children to assess their need for treatment or other psychosocial interventi |
280) nor disagreements, which would not affect treatment or prognosis, were present in 21 |
281) disagreements, which would affect either treatment or prognosis, were present in 37 |
282) Furthermore, randomness of treatment allocation could be significantl |
283) ariate are prevented with a small cost in treatment allocation randomness. |
284) ous types, and preserve the randomness of treatment allocation. |
285) Minimization lacks the randomness of treatment allocation. |
286) alysis, refugees had greater odds of LTBI treatment completion (Adjusted Odds Ratio |
287) Overall, LTBI treatment completion remains suboptimal. |
288) At BCHD-TB, LTBI treatment completion was significantly hig |
289) , and to identify factors associated with treatment completion. |
290) imum efficiency (maximum variance) of the treatment effect estimator. |
291) three degrees of freedom score tests for treatment effect in the TED and give formu |
292) or rate and power for hypothesis test for treatment effect on continuous outcomes ar |
293) and Health Survey to estimate the average treatment effect on the treated, it is fou |
294) s developing severe adverse effects under treatment showed significantly lower basal |
295) l predictions of the osteochondral defect treatment showed that the shear stress at |
296) Short and long-term bendiocarb treatment showed the central vein thickene |
297) Different methods of treatment showed varied success but none i |
|